Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 24 of 24 entries
View as:

Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelanotide Alone or With Zofran

Phase: N/A Priority: Normal
NCT ID: NCT03973047 Org: User:
Start: 06/17/19 End: 07/20/19 Due: 07/20/20

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT02937766 Org: User:
Start: 10/07/16 End: 03/27/17 Due: 03/27/18

Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT04593784 Org: User:
Start: 10/13/21 End: 08/26/23 Due: 08/26/24

A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth

Phase: N/A Priority: Normal
NCT ID: NCT01146990 Org: User:
Start: 11/09/10 End: 08/13/20 Due: 08/13/21

Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Delivery

Phase: N/A Priority: Normal
NCT ID: NCT01004029 Org: User:
Start: 10/31/09 End: 10/31/18 Due: 10/31/19

A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01114139 Org: User:
Start: 06/19/10 End: 10/22/12 Due: 10/22/13

A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03893045 Org: User:
Start: 09/18/19 End: 10/31/25 Due: 10/31/26

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01114217 Org: User:
Start: 07/27/10 End: 04/23/13 Due: 04/23/14

A Crossover Safety Study of Ferumoxytol Versus Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00255450 Org: User:
Start: 01/31/05 End: 08/31/06 Due: 08/31/07

A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01114204 Org: User:
Start: 08/10/10 End: 06/25/12 Due: 06/25/13

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

Phase: N/A Priority: Normal
NCT ID: NCT03619850 Org: User:
Start: 08/13/18 End: 08/31/24 Due: 08/31/25

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01227616 Org: User:
Start: 08/31/13 End: 02/28/17 Due: 02/28/18

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01264679 Org: User:
Start: 12/27/11 End: 04/24/15 Due: 04/24/16

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT02940522 Org: User:
Start: 09/30/16 End: 03/31/17 Due: 03/31/18

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01155388 Org: User:
Start: 10/17/11 End: 06/24/14 Due: 06/24/15

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00255437 Org: User:
Start: 06/30/04 End: 11/30/06 Due: 11/30/07

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00233597 Org: User:
Start: 08/31/04 End: 03/31/07 Due: 03/31/08

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Phase: N/A Priority: Normal
NCT ID: NCT02694978 Org: User:
Start: 02/29/16 End: 07/17/17 Due: 07/17/18

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT00255424 Org: User:
Start: 05/31/04 End: 08/31/06 Due: 08/31/07

A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women

Phase: N/A Priority: Normal
NCT ID: NCT00360425 Org: User:
Start: 05/31/06 End: 08/31/06 Due: 08/31/07

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01155375 Org: User:
Start: 10/17/11 End: 06/24/14 Due: 06/24/15

Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclampsia

Phase: N/A Priority: Normal
NCT ID: NCT03008616 Org: User:
Start: 04/12/17 End: 08/13/20 Due: 08/13/21

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

Phase: N/A Priority: Normal
NCT ID: NCT00707876 Org: User:
Start: 09/30/08 End: 08/31/19 Due: 08/31/20

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01052779 Org: User:
Start: 03/01/10 End: 04/19/12 Due: 04/19/13